Global Follicular Lymphoma Drugs Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Follicular Lymphoma Drugs Market Size Growth Rate by Type (2021-2027)
  • 1.2.2 Chemotherapy Drug
  • 1.2.3 Monoclonal Antibody
  • 1.2.4 Kinase Inhibitor
  • 1.2.5 CAR T-cell Therapy
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Follicular Lymphoma Drugs Market Share by Patient Age (2021-2027)
  • 1.3.2 < 55
  • 1.3.3 55-64
  • 1.3.4 65+
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Follicular Lymphoma Drugs Market Size
• 2.2 Follicular Lymphoma Drugs Market Size by Regions
  • 2.2.1 Follicular Lymphoma Drugs Growth Rate by Regions (2021-2027)
  • 2.2.2 Follicular Lymphoma Drugs Market Share by Regions (2021-2027)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Use Cases

3 Key Players

• 3.1 Follicular Lymphoma Drugs Revenue by Players (2020-2021)
• 3.2 Follicular Lymphoma Drugs Key Players Headquaters and Area Served
• 3.3 Key Players Follicular Lymphoma Drugs Product/Solution/Service
• 3.4 Date of Enter into Follicular Lymphoma Drugs Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Patient Age

• 4.1 Global Follicular Lymphoma Drugs Market Size by Type (2021-2027)
• 4.2 Global Follicular Lymphoma Drugs Market Size by Patient Age (2021-2027)

5 North America

• 5.1 North America Follicular Lymphoma Drugs Market Forecast (2021-2027)
• 5.2 Follicular Lymphoma Drugs Key Players in North America
• 5.3 North America Follicular Lymphoma Drugs Market Size by Type
• 5.4 North America Follicular Lymphoma Drugs Market Size by Patient Age
  • 6.4.4 Canada

6 Europe

• 6.1 Europe Follicular Lymphoma Drugs Market Forecast (2021-2027)
• 6.2 Follicular Lymphoma Drugs Key Players in Europe
• 6.3 Europe Follicular Lymphoma Drugs Market Size by Type
• 6.4 Europe Follicular Lymphoma Drugs Market Size by Patient Age

7 Japan

• 7.1 Japan Follicular Lymphoma Drugs Market Forecast (2021-2027)
• 7.2 Follicular Lymphoma Drugs Key Players in Europe
• 7.3 Japan Follicular Lymphoma Drugs Market Size by Type
• 7.4 Japan Follicular Lymphoma Drugs Market Size by Patient Age

8 Rest of World

• 8.1 China
  • 8.1.1 China Follicular Lymphoma Drugs Market Analysis
  • 8.1.2 Key Players in China
• 8.2 Southeast Asia
  • 8.2.1 Southeast Asia Follicular Lymphoma Drugs Market Analysis
  • 8.2.2 Key Players in Southeast Asia
• 8.3 India
  • 8.3.1 India Follicular Lymphoma Drugs Market Analysis
  • 8.3.2 Key Players in India

9 International Player Profiles

• 9.1 Genentech (Roche)
  • 9.1.1 Genentech (Roche) Company Details
  • 9.1.2 Genentech (Roche) Description and Business Overview
  • 9.1.3 Genentech (Roche) Follicular Lymphoma Drugs Introduction
  • 9.1.4 Genentech (Roche) Revenue in Follicular Lymphoma Drugs Business (2020-2021)
  • 9.1.5 Genentech (Roche) Recent Development
• 9.2 Bristol-Myers Squibb
  • 9.2.1 Bristol-Myers Squibb Company Details
  • 9.2.2 Bristol-Myers Squibb Description and Business Overview
  • 9.2.3 Bristol-Myers Squibb Follicular Lymphoma Drugs Introduction
  • 9.2.4 Bristol-Myers Squibb Revenue in Follicular Lymphoma Drugs Business (2020-2021)
  • 9.2.5 Bristol-Myers Squibb Recent Development
• 9.3 Gilead Sciences
  • 9.3.1 Gilead Sciences Company Details
  • 9.3.2 Gilead Sciences Description and Business Overview
  • 9.3.3 Gilead Sciences Follicular Lymphoma Drugs Introduction
  • 9.3.4 Gilead Sciences Revenue in Follicular Lymphoma Drugs Business (2020-2021)
  • 9.3.5 Gilead Sciences Recent Development
• 9.4 TG Therapeutics
  • 9.4.1 TG Therapeutics Company Details
  • 9.4.2 TG Therapeutics Description and Business Overview
  • 9.4.3 TG Therapeutics Follicular Lymphoma Drugs Introduction
  • 9.4.4 TG Therapeutics Revenue in Follicular Lymphoma Drugs Business (2020-2021)
  • 9.4.5 TG Therapeutics Recent Development
• 9.5 Bayer
  • 9.5.1 Bayer Company Details
  • 9.5.2 Bayer Description and Business Overview
  • 9.5.3 Bayer Follicular Lymphoma Drugs Introduction
  • 9.5.4 Bayer Revenue in Follicular Lymphoma Drugs Business (2020-2021)
  • 9.5.5 Bayer Recent Development
• 9.6 Secura Bio
  • 9.6.1 Secura Bio Company Details
  • 9.6.2 Secura Bio Description and Business Overview
  • 9.6.3 Secura Bio Follicular Lymphoma Drugs Introduction
  • 9.6.4 Secura Bio Revenue in Follicular Lymphoma Drugs Business (2020-2021)
  • 9.6.5 Secura Bio Recent Development
• 9.7 Epizyme
  • 9.7.1 Epizyme Company Details
  • 9.7.2 Epizyme Description and Business Overview
  • 9.7.3 Epizyme Follicular Lymphoma Drugs Introduction
  • 9.7.4 Epizyme Revenue in Follicular Lymphoma Drugs Business (2020-2021)
  • 9.7.5 Epizyme Recent Development
• 9.8 Jazz Pharmaceuticals
  • 9.8.1 Jazz Pharmaceuticals Company Details
  • 9.8.2 Jazz Pharmaceuticals Description and Business Overview
  • 9.8.3 Jazz Pharmaceuticals Follicular Lymphoma Drugs Introduction
  • 9.8.4 Jazz Pharmaceuticals Revenue in Follicular Lymphoma Drugs Business (2020-2021)
  • 9.8.5 Jazz Pharmaceuticals Recent Development

10 Market Dynamics

• 10.1 Industry Trends
• 10.2 Market Drives
• 10.3 Market Challenges
• 10.4 Market Restraints

11 Key Findings in This Report

12 Appendix

• 12.1 Research Methodology
  • 12.1.1 Methodology/Research Approach
  • 12.1.2 Data Source
• 12.2 Disclaimer